MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Sep 11, 2025 · CIK: 1878313
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
MAIA filed an 8-K on 9/11/25 for 'Other Events' and financials - details TBD.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on September 11, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only that they were reported on this date.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, but the lack of specific details means investors cannot yet assess any immediate impact.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- September 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (other) — Commission File Number
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL (location) — Principal executive offices city and state
- 60606 (zip_code) — Principal executive offices zip code
- 312-416-8592 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by MAIA Biotechnology, Inc. in this 8-K filing?
The filing indicates "Other Events" as an item reported, but does not provide specific details within the provided text.
What is the nature of the "Financial Statements and Exhibits" being filed?
The filing lists "Financial Statements and Exhibits" as an item, but the specific content of these statements and exhibits is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 11, 2025.
What is MAIA Biotechnology, Inc.'s state of incorporation and commission file number?
MAIA Biotechnology, Inc. is incorporated in Delaware and its commission file number is 001-41455.
What is the principal executive office address and phone number for MAIA Biotechnology, Inc.?
The principal executive office is located at 444 West Lake Street, Suite 1700, Chicago, IL 60606, and the telephone number is (312) 416-8592.
Filing Stats: 772 words · 3 min read · ~3 pages · Grade level 14.4 · Accepted 2025-09-11 16:05:45
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-013074.txt ( ) — 235KB
- maia-20250911.xsd (EX-101.SCH) — 3KB
- maia-20250911_lab.xml (EX-101.LAB) — 33KB
- maia-20250911_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 11, 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3